APPROACHES TO GENE-THERAPY OF COMPLEX MULTIGENIC DISEASES - CANCER AS A MODEL AND IMPLICATIONS FOR CARDIOVASCULAR-DISEASE AND DIABETES

被引:7
作者
FRIEDMANN, T
机构
[1] Center for Molecular Genetics, UCSD School of Medicine, CA
关键词
GENE THERAPY; MULTIGENIC; CANCER; NEURODEGENERATIVE; TUMOR SUPPRESSOR; IMMUNOTHERAPY;
D O I
10.3109/07853899209147847
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The general concept of gene therapy is now well established and accepted by the medical, scientific and public policy communities, and is rapidly being implemented in human experimental studies. In addition to the initial models of single gene defects, target diseases have now come to include multigenic and multifactorial diseases such as human cancer, neurodegenerative diseases such as Parkinson's disease and firms of cardiovascular disease. While many conceptual and technical obstacles must still be overcome before therapy for disorders such as coronary artery disease and diabetes mellitus will easily be approached at the genetic level, the early results with several multigenic disease models gives some cause for optimism that gene therapies for even those complicated disorders will eventually become available.
引用
收藏
页码:411 / 417
页数:7
相关论文
共 58 条
[1]   SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53 [J].
BAKER, SJ ;
MARKOWITZ, S ;
FEARON, ER ;
WILLSON, JKV ;
VOGELSTEIN, B .
SCIENCE, 1990, 249 (4971) :912-915
[2]   THE NF1 LOCUS ENCODES A PROTEIN FUNCTIONALLY RELATED TO MAMMALIAN GAP AND YEAST IRA PROTEINS [J].
BALLESTER, R ;
MARCHUK, D ;
BOGUSKI, M ;
SAULINO, A ;
LETCHER, R ;
WIGLER, M ;
COLLINS, F .
CELL, 1990, 63 (04) :851-859
[3]   ASSOCIATION OF THE RAS-ANTAGONISTIC RAP1/KREV-1 PROTEINS WITH THE GOLGI-COMPLEX [J].
BERANGER, F ;
GOUD, B ;
TAVITIAN, A ;
DEGUNZBURG, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (05) :1606-1610
[4]  
BERKNER KL, 1988, BIOTECHNIQUES, V6, P616
[5]  
BISHOP JM, 1983, CELL, V32, P1018
[6]   MOLECULAR THEMES IN ONCOGENESIS [J].
BISHOP, JM .
CELL, 1991, 64 (02) :235-248
[7]   EFFECT OF A DOMINANT INHIBITORY HA-RAS MUTATION ON MITOGENIC SIGNAL TRANSDUCTION IN NIH 3T3 CELLS [J].
CAI, H ;
SZEBERENYI, J ;
COOPER, GM .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (10) :5314-5323
[8]  
CALABRETTA B, 1991, CANCER RES, V51, P4505
[9]  
CASEY G, 1991, ONCOGENE, V6, P1791
[10]  
CECH TR, 1988, JAMA-J AM MED ASSOC, V260, P327